Trofimov, Ivan A. https://orcid.org/0000-0002-3773-7490
Salnikov, Oleg G. https://orcid.org/0000-0003-2266-7335
Pravdivtsev, Andrey N. https://orcid.org/0000-0002-8763-617X
de Maissin, Henri https://orcid.org/0000-0003-3505-1572
Yi, Anna P.
Chekmenev, Eduard Y. https://orcid.org/0000-0002-8745-8801
Hövener, Jan-Bernd https://orcid.org/0000-0001-7255-7252
Schmidt, Andreas B. https://orcid.org/0000-0001-8944-7463
Koptyug, Igor V. https://orcid.org/0000-0003-3480-7649
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (13N16448, 01ZX1915C, 13N16448, 01ZX1915C, 13N16448)
Deutsche Forschungsgemeinschaft (#SCHM 3694/1, #SCHM 3694/2, #SFB1479, Project ID: 441891347SFB1160, PR 1868/3-1, PR 1868/5-1, HO-4602/2-2, HO-4602/3, EXC2167, FOR5042, TRR287, #SCHM 3694/1, #SCHM 3694/2, #SFB1479, Project ID: 441891347SFB1160, PR 1868/3-1, PR 1868/5-1, HO-4602/2-2, HO-4602/3, EXC2167, FOR5042, TRR287, #SCHM 3694/1, #SCHM 3694/2, #SFB1479, Project ID: 441891347SFB1160)
German Cancer Consortium (DKTK), the DKTK Joint Funding project “HYPERBOLIC”
Russian Science Foundation (#22-43-04426, #22-43-04426, #22-43-04426)
EC | European Regional Development Fund (122-09-053, 122-09-053)
National Science Foundation (CHE-1904780, NIBIB R01EB034197, NHLBI 1R21HL154032, DOD CDMRP W81XWH-20-10576)
Wayne State University (Postdoctoral Fellow award, Postdoctoral Fellow award)
Article History
Received: 17 June 2024
Accepted: 20 September 2024
First Online: 16 October 2024
Competing interests
: E.Y.C. declares a stake of ownership in XeUS Technologies, Ltd. E.Y.C. also holds stock of Vizma Life Sciences (VLS) and serves on the scientific advisory board (SAB) of VLS. The remaining authors declare no competing interests.